Stoma Hernia Intraperitoneal Full-Thickness Skin
Launched by UMEÅ UNIVERSITY · Sep 10, 2018
Trial Information
Current as of May 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different surgical methods to repair a condition called parastomal hernia, which can occur in people who have had certain types of surgeries to create a stoma (an opening on the abdomen for waste removal). The study is currently recruiting participants aged 65 to 74 who have a diagnosed parastomal hernia and are experiencing symptoms that require surgery. To take part, individuals must be over 18 years old, have a stoma (like a colostomy or ileostomy), and be able to understand and respond to questionnaires in Swedish.
Participants in the trial will receive one of the surgical treatments being tested and will be monitored for their recovery. It’s important to note that those with certain conditions, such as cognitive impairments or other complications related to their stoma, may not be eligible to join. This study aims to find out which surgical method is more effective, ultimately helping improve care for people with parastomal hernias. If you or someone you know fits the criteria and is interested in participating, it could be a valuable opportunity to contribute to medical knowledge in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Colo-, ileo- or urostomy
- • Parastomal hernia diagnosed with intrastomal ultrasound and/or CT
- • Symptoms from the parastomal hernia requiring surgical intervention
- • Informed consent
- • \>18 years of age
- • Sufficient knowledge in the Swedish language so that questionnaires can be answered
- Exclusion Criteria:
- • Cognitive impairment unabling compliance to post-operative prescriptions and/or answering questionnaires
- • Insufficient amount of good quality skin suitable for transplantation
- • Expected high donor-site morbidity
- • Fistula/e adjacent to stoma
- • Mb Crohn
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Luleå, Norrbotten, Sweden
Umeå, Västerbotten, Sweden
Patients applied
Trial Officials
Karin Strigård, PhD
Principal Investigator
Umeå University, Department of Surgical and Perioperative sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials